Tuesday, 02 January 2024 12:17 GMT

Final Deadline Today For The Intellia Therapeutics, Inc. Securities Lawsuit - Contact The DJS Law Group To Discuss Your Rights - NTLA


(MENAFN- PR Newswire)

LOS ANGELES, April 14, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Intellia Therapeutics ("Intellia" or "the Company") (NASDAQ: NTLA ) for violations of the federal securities laws.

Shareholders who purchased the Company's securities between July 30, 2024 and January 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.

CASE DETAILS: According to the Complaint, Intellia made false and misleading statements to the market when it allegedly gave investors the false impression that it had reliable information about the development and marketing of NTLA-3001. The Company's reports on timelines including future studies of its drug were not sustainable or viable due to expensive and inefficient delivery methods. The Company was not capable of providing patients with timely doses of NTLA-3001 or even to maintain full staffing

If you are a shareholder who suffered a loss, contact us to participate .

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

Eastchester, NY 10709

Phone: 914-206-9742

Email: [email protected]

SOURCE DJS Law Group LLP

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN14042025003732001241ID1109427970


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search